-
Safety Shield Study for ADALIMUMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for USTEKINUMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for UPADACITINIB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for TOFACITINIB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for TILDRAKIZUMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for SECUKINUMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for RISANKIZUMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for IXEKIZUMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for INFLIXIMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for GUSELKUMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for GOLIMUMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for ETANERCEPT
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for CERTOLIZUMAB PEGOL
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for BRODALUMAB
Regular price From €800,00 EURRegular priceUnit price per -
Safety Shield Study for APREMILAST
Regular price From €800,00 EURRegular priceUnit price per
Explore our exclusive study series
-
Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80%...
-
Expert Mapping Studies
Expert Mapping Reports cut screening time by 10 days and reduce failed...
-
Clinical Endpoints Studies
This targeted analysis delivers a robust assessment of clinical endpoints tailored to...
